JP Morgan Chase
LENZ

JP Morgan Chase’s LENZ Therapeutics LENZ Stock Holding History

JP Morgan Chase’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69K Buy
11,981
+1,098
+10% +$8.85K ﹤0.01% 6280
2026
Q1 		$90.2K Buy
10,883
+1,418
+15% +$19.9K ﹤0.01% 5886
2025
Q4 		$151K Sell
9,465
-1,757
-16% -$51.2K ﹤0.01% 5667
2025
Q3 		$523K Buy
11,222
+861
+8% +$31.7K ﹤0.01% 5003
2025
Q2 		$304K Buy
10,361
+2,310
+29% +$62.8K ﹤0.01% 5022
2025
Q1 		$207K Sell
8,051
-291
-3% -$7.17K ﹤0.01% 5225
2024
Q4 		$241K Buy
8,342
+2,643
+46% +$80.6K ﹤0.01% 5398
2024
Q3 		$135K Buy
5,699
+279
+5% +$6.19K ﹤0.01% 5581
2024
Q2 		$93.7K Buy
5,420
+3,738
+222% +$65.3K ﹤0.01% 5543
2024
Q1 		$37.6K Sell
1,682
-913
-35% -$19K ﹤0.01% 6040
2023
Q4 		$47.6K Sell
2,595
-1,504
-37% -$24.8K ﹤0.01% 6014
2023
Q3 		$71.2K Buy
4,099
+691
+20% +$12K ﹤0.01% 5673
2023
Q2 		$62K Buy
3,408
+3,198
+1,523% +$63.9K ﹤0.01% 5659
2023
Q1 		$4K Sell
210
-349
-62% -$5.64K ﹤0.01% 6311
2022
Q4 		$13K Sell
559
-337
-38% -$7.81K ﹤0.01% 5987
2022
Q3 		$20K Buy
896
+175
+24% +$4.17K ﹤0.01% 5809
2022
Q2 		$14K Sell
721
-2,211
-75% -$49.3K ﹤0.01% 5977
2022
Q1 		$105K Buy
2,932
+1,311
+81% +$82K ﹤0.01% 5484
2021
Q4 		$141K Buy
1,621
+732
+82% +$60.6K ﹤0.01% 5533
2021
Q3 		$102K Buy
+889
New +$132K ﹤0.01% 5557

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

JP Morgan Chase's LENZ Position: Q2 2026 in Review

JP Morgan Chase increased its LENZ Therapeutics (LENZ) stake by 10% in Q2 2026, buying an estimated $8.85K and bringing the position to 11,981 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #6280.

JP Morgan Chase first reported a position in LENZ in Q3 2021 and has held it in 20 quarters since. The position peaked at $523K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • JP Morgan Chase held 11,981 shares of LENZ Therapeutics worth $69K as of Q2 2026.
  • JP Morgan Chase bought 1,098 LENZ Therapeutics shares in Q2 2026, an estimated $8.85K.
  • LENZ Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6280 holding.
  • JP Morgan Chase first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's LENZ Therapeutics position peaked at $523K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.